
Gossamer Bio, Inc.
GOSSHealthcare|Biotechnology|US
$9.77
+0.35 (+3.72%)
DCF Value
$117.58
Cash / Share
$20.66
Ownership Breakdown
26.3%
Float
6.1M
Shares Outstanding
1.6M
Float Shares
Major Holders (40)
Combined: 216.4%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Abigail P. Johnson | Individual | 10.90% | 667,465 | Nov 6, 2026 | 13D/G |
| FMR LLC | Holding company | 10.90% | 667,465 | Nov 6, 2026 | 13D/G |
| Ari Zweiman | Individual | 9.99% | 49,868,571 | Jun 11, 2026 | 13D/G |
| 683 Capital Management, LLC | Investment adviser | 9.99% | 49,868,571 | Jun 11, 2026 | 13D/G |
| 683 Capital Partners, LP | Partnership | 9.99% | 49,868,571 | Jun 11, 2026 | 13D/G |
| Michael S. Rosen | HC, IN | 9.90% | 48,835,788 | Jun 9, 2026 | 13D/G |
| Context Capital Management, LLC | IA, OO | 9.90% | 48,835,788 | Jun 9, 2026 | 13D/G |
| Context Partners Master Fund, L.P. | Partnership | 9.90% | 48,835,788 | Jun 9, 2026 | 13D/G |
| William D. Fertig | HC, IN | 9.90% | 48,835,788 | Jun 9, 2026 | 13D/G |
| Charles E. Carnegie | HC, IN | 9.90% | 48,835,788 | Jun 9, 2026 | 13D/G |
| Octagon Investments Master Fund | PN, OO | 8.60% | 19,576,054 | Feb 5, 2025 | 13D/G |
| DeepCurrents Investment Group LLC | Investment adviser | 7.70% | 37,665,073 | Jun 11, 2026 | 13D/G |
| Kai Zheng | HC, IN | 7.70% | 37,665,073 | Jun 11, 2026 | 13D/G |
| Opaleye Management Inc. | IA, CO | 6.98% | 426,989 | Nov 6, 2026 | 13D/G |
| James Silverman | Individual | 6.98% | 426,989 | Nov 6, 2026 | 13D/G |
| Opaleye, L.P. | Partnership | 6.79% | 415,000 | Nov 6, 2026 | 13D/G |
| Dcig GP LLC | Other | 5.70% | 27,646,139 | Jun 11, 2026 | 13D/G |
| DCIG Capital Master Fund LP | Other | 5.70% | 27,646,139 | Jun 11, 2026 | 13D/G |
| D. E. Shaw & Co., L.L.C. | Other | 4.20% | 255,431 | Oct 29, 2026 | 13D/G |
| David E. Shaw | Individual | 4.20% | 255,431 | Oct 29, 2026 | 13D/G |
| D. E. Shaw & Co., L.P. | IA, PN | 4.20% | 255,431 | Oct 29, 2026 | 13D/G |
| D. E. Shaw Valence Portfolios, L.L.C. | Other | 4.00% | 243,041 | Oct 29, 2026 | 13D/G |
| Ting Jia | HC, IN | 3.80% | 8,976,054 | May 14, 2026 | 13D/G |
| Octagon Capital Advisors LP | IA, PN | 3.80% | 8,976,054 | May 14, 2026 | 13D/G |
| Octagon Investments Master Fund LP | PN, OO | 3.80% | 8,976,054 | May 14, 2026 | 13D/G |
| Invus Public Equities Advisors, LLC | Other | 2.80% | 6,258,880 | Feb 12, 2025 | 13D/G |
| Invus Global Management, LLC | Other | 2.80% | 6,258,880 | Feb 12, 2025 | 13D/G |
| Siren, L.L.C. | Other | 2.80% | 6,258,880 | Feb 12, 2025 | 13D/G |
| Raymond Debbane | Individual | 2.80% | 6,258,880 | Feb 12, 2025 | 13D/G |
| Invus Public Equities, L.P. | Partnership | 2.80% | 6,258,880 | Feb 12, 2025 | 13D/G |
| NEA 18 Venture Growth Equity, L.P. | Partnership | 1.70% | 4,065,134 | Feb 24, 2026 | 13D/G |
| Rick Yang | Individual | 1.70% | 4,065,134 | Feb 24, 2026 | 13D/G |
| Paul Walker | Individual | 1.70% | 4,065,134 | Feb 24, 2026 | 13D/G |
| Scott D. Sandell | Individual | 1.70% | 4,065,134 | Feb 24, 2026 | 13D/G |
| Growth Equity Opportunities 18 VGE, LLC | Other | 1.70% | 4,065,134 | Feb 24, 2026 | 13D/G |
| NEA Partners 18 VGE, L.P. | Partnership | 1.70% | 4,065,134 | Feb 24, 2026 | 13D/G |
| Nea 18 Vge GP, LLC | Other | 1.70% | 4,065,134 | Feb 24, 2026 | 13D/G |
| Ali Behbahani | Individual | 1.70% | 4,065,134 | Feb 24, 2026 | 13D/G |
| Edward T. Mathers | Individual | 1.70% | 4,065,134 | Feb 24, 2026 | 13D/G |
| Mohamad H. Makhzoumi | Individual | 1.70% | 4,065,134 | Feb 24, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 49,734,827 acquired · 16,589,751 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Milligan Sandra | director | Sep 23, 2026 | AWARD | 10,000 | $10.99 | $109.9K | Form 4 |
| Daniel Thomas O | director | Sep 23, 2026 | AWARD | 10,000 | $10.99 | $109.9K | Form 4 |
| Ciongoli Gregory Austin | director | Sep 23, 2026 | AWARD | 30,000 | $10.99 | $329.7K | Form 4 |
| Drynan Skye | director | Sep 23, 2026 | AWARD | 10,000 | $10.99 | $109.9K | Form 4 |
| Quisel John D | director | Sep 23, 2026 | AWARD | 10,000 | $10.99 | $109.9K | Form 4 |
| Cox Russell J. | director | Sep 23, 2026 | AWARD | 10,000 | $10.99 | $109.9K | Form 4 |
| Nathan Steven D | director | Sep 23, 2026 | AWARD | 10,000 | $10.99 | $109.9K | Form 4 |
| Ciongoli Gregory Austin | director | Aug 24, 2026 | OTHER | 250 | $0.00 | $0.03 | Form 4 |
| Christian Waage | EVP, Tech Ops and Admin | Aug 24, 2026 | AWARD | 2,900,026 | $0.17 | $507.5K | Form 4 |
| Peterson Caryn | Chief Development Officer | Aug 24, 2026 | AWARD | 5,800,051 | $0.17 | $1.0M | Form 4 |
| Smith Robert Paul JR | Chief Commercial Officer | Aug 24, 2026 | AWARD | 5,800,051 | $0.17 | $1.0M | Form 4 |
| Giraudo Bryan | COO/CFO | Aug 24, 2026 | AWARD | 5,800,051 | $0.17 | $1.0M | Form 4 |
| Giraudo Bryan | COO/CFO | Aug 24, 2026 | AWARD | 25 | $0.00 | $0.00 | Form 4 |
| Hasnain Faheem | director, officer: President & CEO | Aug 24, 2026 | AWARD | 5,800,051 | $0.17 | $1.0M | Form 4 |
| Hasnain Faheem | director, officer: President & CEO | Aug 24, 2026 | AWARD | 166 | $0.00 | $0.02 | Form 4 |
| Quisel John D | director | Jun 4, 2026 | AWARD | 115,000 | $0.18 | $20.5K | Form 4 |
| Drynan Skye | director | Jun 4, 2026 | AWARD | 115,000 | $0.18 | $20.5K | Form 4 |
| Daniel Thomas O | director | Jun 4, 2026 | AWARD | 115,000 | $0.18 | $20.5K | Form 4 |
| Cox Russell J. | director | Jun 4, 2026 | AWARD | 115,000 | $0.18 | $20.5K | Form 4 |
| Milligan Sandra | director | Jun 4, 2026 | AWARD | 115,000 | $0.18 | $20.5K | Form 4 |
| Nathan Steven D | director | Jun 4, 2026 | AWARD | 115,000 | $0.18 | $20.5K | Form 4 |
| Aranda Richard | Chief Medical Officer | Mar 19, 2026 | AWARD | 572,000 | $0.45 | $257.4K | Form 4 |
| Aranda Richard | Chief Medical Officer | Mar 19, 2026 | AWARD | 562,500 | $0.45 | $253.1K | Form 4 |
| Aranda Richard | Chief Medical Officer | Mar 19, 2026 | AWARD | 487,500 | $0.45 | $219.4K | Form 4 |
| Aranda Richard | Chief Medical Officer | Mar 19, 2026 | AWARD | 162,500 | $0.45 | $73.1K | Form 4 |
| Aranda Richard | Chief Medical Officer | Mar 19, 2026 | AWARD | 157,500 | $0.45 | $70.9K | Form 4 |
| Aranda Richard | Chief Medical Officer | Mar 19, 2026 | AWARD | 126,667 | $0.45 | $57.0K | Form 4 |
| Aranda Richard | Chief Medical Officer | Mar 19, 2026 | AWARD | 40,000 | $0.45 | $18.0K | Form 4 |
| Aranda Richard | Chief Medical Officer | Mar 19, 2026 | AWARD | 30,000 | $0.45 | $13.5K | Form 4 |
| Aranda Richard | Chief Medical Officer | Mar 19, 2026 | AWARD | 22,784 | $0.45 | $10.3K | Form 4 |
| Aranda Richard | Chief Medical Officer | Mar 19, 2026 | AWARD | 20,000 | $0.45 | $9.0K | Form 4 |
| Aranda Richard | Chief Medical Officer | Mar 19, 2026 | AWARD | 9,167 | $0.45 | $4.1K | Form 4 |
| Aranda Richard | Chief Medical Officer | Mar 19, 2026 | DISPOSED | 157,500 | $1.21 | $190.6K | Form 4 |
| Aranda Richard | Chief Medical Officer | Mar 19, 2026 | DISPOSED | 162,500 | $0.84 | $136.2K | Form 4 |
| Aranda Richard | Chief Medical Officer | Mar 19, 2026 | DISPOSED | 487,500 | $0.97 | $472.9K | Form 4 |
| Aranda Richard | Chief Medical Officer | Mar 19, 2026 | DISPOSED | 562,500 | $2.88 | $1.6M | Form 4 |
| Aranda Richard | Chief Medical Officer | Mar 19, 2026 | DISPOSED | 572,000 | $1.13 | $646.4K | Form 4 |
| Aranda Richard | Chief Medical Officer | Mar 19, 2026 | DISPOSED | 30,000 | $1.36 | $40.8K | Form 4 |
| Aranda Richard | Chief Medical Officer | Mar 19, 2026 | DISPOSED | 157,500 | $2.16 | $340.2K | Form 4 |
| Peterson Caryn | EVP, Regulatory Affairs | Mar 19, 2026 | AWARD | 506,250 | $0.45 | $227.8K | Form 4 |
| Peterson Caryn | EVP, Regulatory Affairs | Mar 19, 2026 | AWARD | 440,000 | $0.45 | $198.0K | Form 4 |
| Peterson Caryn | EVP, Regulatory Affairs | Mar 19, 2026 | AWARD | 375,000 | $0.45 | $168.8K | Form 4 |
| Peterson Caryn | EVP, Regulatory Affairs | Mar 19, 2026 | AWARD | 157,500 | $0.45 | $70.9K | Form 4 |
| Peterson Caryn | EVP, Regulatory Affairs | Mar 19, 2026 | AWARD | 126,667 | $0.45 | $57.0K | Form 4 |
| Peterson Caryn | EVP, Regulatory Affairs | Mar 19, 2026 | AWARD | 125,000 | $0.45 | $56.3K | Form 4 |
| Peterson Caryn | EVP, Regulatory Affairs | Mar 19, 2026 | AWARD | 32,334 | $0.45 | $14.6K | Form 4 |
| Peterson Caryn | EVP, Regulatory Affairs | Mar 19, 2026 | AWARD | 22,784 | $0.45 | $10.3K | Form 4 |
| Peterson Caryn | EVP, Regulatory Affairs | Mar 19, 2026 | AWARD | 21,167 | $0.45 | $9.5K | Form 4 |
| Peterson Caryn | EVP, Regulatory Affairs | Mar 19, 2026 | AWARD | 18,834 | $0.45 | $8.5K | Form 4 |
| Peterson Caryn | EVP, Regulatory Affairs | Mar 19, 2026 | AWARD | 9,167 | $0.45 | $4.1K | Form 4 |
| Peterson Caryn | EVP, Regulatory Affairs | Mar 19, 2026 | DISPOSED | 506,250 | $2.88 | $1.5M | Form 4 |
| Peterson Caryn | EVP, Regulatory Affairs | Mar 19, 2026 | DISPOSED | 440,000 | $1.13 | $497.2K | Form 4 |
| Peterson Caryn | EVP, Regulatory Affairs | Mar 19, 2026 | DISPOSED | 375,000 | $0.97 | $363.8K | Form 4 |
| Peterson Caryn | EVP, Regulatory Affairs | Mar 19, 2026 | DISPOSED | 125,000 | $0.84 | $104.8K | Form 4 |
| Peterson Caryn | EVP, Regulatory Affairs | Mar 19, 2026 | DISPOSED | 157,500 | $1.21 | $190.6K | Form 4 |
| Peterson Caryn | EVP, Regulatory Affairs | Mar 19, 2026 | DISPOSED | 157,500 | $2.16 | $340.2K | Form 4 |
| Peterson Caryn | EVP, Regulatory Affairs | Mar 19, 2026 | DISPOSED | 32,334 | $1.36 | $44.0K | Form 4 |
| Smith Robert Paul JR | Chief Commercial Officer | Mar 19, 2026 | AWARD | 572,000 | $0.45 | $257.4K | Form 4 |
| Smith Robert Paul JR | Chief Commercial Officer | Mar 19, 2026 | AWARD | 562,500 | $0.45 | $253.1K | Form 4 |
| Smith Robert Paul JR | Chief Commercial Officer | Mar 19, 2026 | DISPOSED | 562,500 | $2.88 | $1.6M | Form 4 |
| Smith Robert Paul JR | Chief Commercial Officer | Mar 19, 2026 | DISPOSED | 572,000 | $1.13 | $646.4K | Form 4 |
| Hasnain Faheem | director, officer: President & CEO | Mar 19, 2026 | AWARD | 1,680,000 | $0.45 | $756.0K | Form 4 |
| Hasnain Faheem | director, officer: President & CEO | Mar 19, 2026 | AWARD | 1,540,000 | $0.45 | $693.0K | Form 4 |
| Hasnain Faheem | director, officer: President & CEO | Mar 19, 2026 | AWARD | 1,312,500 | $0.45 | $590.6K | Form 4 |
| Hasnain Faheem | director, officer: President & CEO | Mar 19, 2026 | AWARD | 650,000 | $0.45 | $292.5K | Form 4 |
| Hasnain Faheem | director, officer: President & CEO | Mar 19, 2026 | AWARD | 544,500 | $0.45 | $245.0K | Form 4 |
| Hasnain Faheem | director, officer: President & CEO | Mar 19, 2026 | AWARD | 437,500 | $0.45 | $196.9K | Form 4 |
| Hasnain Faheem | director, officer: President & CEO | Mar 19, 2026 | AWARD | 325,000 | $0.45 | $146.3K | Form 4 |
| Hasnain Faheem | director, officer: President & CEO | Mar 19, 2026 | AWARD | 47,000 | $0.45 | $21.1K | Form 4 |
| Hasnain Faheem | director, officer: President & CEO | Mar 19, 2026 | AWARD | 43,500 | $0.45 | $19.6K | Form 4 |
| Hasnain Faheem | director, officer: President & CEO | Mar 19, 2026 | DISPOSED | 43,500 | $22.10 | $961.4K | Form 4 |
| Hasnain Faheem | director, officer: President & CEO | Mar 19, 2026 | DISPOSED | 47,000 | $12.10 | $568.7K | Form 4 |
| Hasnain Faheem | director, officer: President & CEO | Mar 19, 2026 | DISPOSED | 325,000 | $9.79 | $3.2M | Form 4 |
| Hasnain Faheem | director, officer: President & CEO | Mar 19, 2026 | DISPOSED | 650,000 | $11.94 | $7.8M | Form 4 |
| Hasnain Faheem | director, officer: President & CEO | Mar 19, 2026 | DISPOSED | 544,500 | $2.16 | $1.2M | Form 4 |
| Hasnain Faheem | director, officer: President & CEO | Mar 19, 2026 | DISPOSED | 544,500 | $1.21 | $658.8K | Form 4 |
| Hasnain Faheem | director, officer: President & CEO | Mar 19, 2026 | DISPOSED | 437,500 | $0.84 | $366.6K | Form 4 |
| Hasnain Faheem | director, officer: President & CEO | Mar 19, 2026 | DISPOSED | 1,312,500 | $0.97 | $1.3M | Form 4 |
| Hasnain Faheem | director, officer: President & CEO | Mar 19, 2026 | DISPOSED | 1,540,000 | $1.13 | $1.7M | Form 4 |
| Hasnain Faheem | director, officer: President & CEO | Mar 19, 2026 | DISPOSED | 1,680,000 | $2.88 | $4.8M | Form 4 |
| Giraudo Bryan | COO/CFO | Mar 19, 2026 | AWARD | 693,750 | $0.45 | $312.2K | Form 4 |
| Giraudo Bryan | COO/CFO | Mar 19, 2026 | AWARD | 638,000 | $0.45 | $287.1K | Form 4 |
| Giraudo Bryan | COO/CFO | Mar 19, 2026 | AWARD | 543,750 | $0.45 | $244.7K | Form 4 |
| Giraudo Bryan | COO/CFO | Mar 19, 2026 | AWARD | 211,500 | $0.45 | $95.2K | Form 4 |
| Giraudo Bryan | COO/CFO | Mar 19, 2026 | AWARD | 181,250 | $0.45 | $81.6K | Form 4 |
| Giraudo Bryan | COO/CFO | Mar 19, 2026 | AWARD | 176,667 | $0.45 | $79.5K | Form 4 |
| Giraudo Bryan | COO/CFO | Mar 19, 2026 | AWARD | 100,000 | $0.45 | $45.0K | Form 4 |
| Giraudo Bryan | COO/CFO | Mar 19, 2026 | AWARD | 96,667 | $0.45 | $43.5K | Form 4 |
| Giraudo Bryan | COO/CFO | Mar 19, 2026 | AWARD | 60,000 | $0.45 | $27.0K | Form 4 |
| Giraudo Bryan | COO/CFO | Mar 19, 2026 | AWARD | 47,667 | $0.45 | $21.5K | Form 4 |
| Giraudo Bryan | COO/CFO | Mar 19, 2026 | DISPOSED | 693,750 | $2.88 | $2.0M | Form 4 |
| Giraudo Bryan | COO/CFO | Mar 19, 2026 | DISPOSED | 638,000 | $1.13 | $720.9K | Form 4 |
| Giraudo Bryan | COO/CFO | Mar 19, 2026 | DISPOSED | 543,750 | $0.97 | $527.4K | Form 4 |
| Giraudo Bryan | COO/CFO | Mar 19, 2026 | DISPOSED | 181,250 | $0.84 | $151.9K | Form 4 |
| Giraudo Bryan | COO/CFO | Mar 19, 2026 | DISPOSED | 211,500 | $1.21 | $255.9K | Form 4 |
| Giraudo Bryan | COO/CFO | Mar 19, 2026 | DISPOSED | 211,500 | $2.16 | $456.8K | Form 4 |
| Giraudo Bryan | COO/CFO | Mar 19, 2026 | DISPOSED | 96,667 | $1.36 | $131.5K | Form 4 |
| Christian Waage | EVP, Tech Ops and Admin | Mar 19, 2026 | AWARD | 506,250 | $0.45 | $227.8K | Form 4 |
| Christian Waage | EVP, Tech Ops and Admin | Mar 19, 2026 | AWARD | 440,000 | $0.45 | $198.0K | Form 4 |
| Christian Waage | EVP, Tech Ops and Admin | Mar 19, 2026 | AWARD | 375,000 | $0.45 | $168.8K | Form 4 |